IRWD - Latest News

Ironwood Pharmaceuticals, Inc. (IRWD), operates in Healthcare / Drug Manufacturers - Specialty & Generic, trades on NASDAQ.

Market capitalization stands near $605.8M. Trailing twelve-month P/E ratio is 5.89. Beta to the broader market is 0.30.

The article list below shows the most recent IRWD headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent IRWD Headlines

Ironwood Pharmaceuticals: CFO Resignation Knocks Shares - A Downgrade Is Due

seekingalpha.com - May 13, 2026

Ironwood Pharmaceuticals is downgraded to Hold after the CFO's resignation and despite record Q1 2026 Linzess-driven revenues. IRWD guides for $1.

Ironwood Pharmaceuticals Q1 Earnings Call Highlights

marketbeat.com - May 8, 2026

Ironwood Pharmaceuticals NASDAQ: IRWD reported a strong start to 2026 and reiterated its full-year outlook, pointing to sharp first-quarter growth for

Ironwood Stock Down Despite Q1 Earnings and Revenue Beat

zacks.com - May 8, 2026

IRWD beats Q1 earnings and revenue estimates with Linzess sales surging on strong demand, but shares slide despite better-than-expected results.

Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2026 Earnings Call Transcript

seekingalpha.com - May 7, 2026

Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals (IRWD) Tops Q1 Earnings and Revenue Estimates

zacks.com - May 7, 2026

Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0. 24 per share, beating the Zacks Consensus Estimate of $0.

How News Affects IRWD Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track IRWD's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked IRWD news questions

What is the latest IRWD news headline?

The most recent IRWD headline (May 13, 2026) is "Ironwood Pharmaceuticals: CFO Resignation Knocks Shares - A Downgrade Is Due". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the IRWD news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What IRWD news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual IRWD options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.